RedHill Biopharma (RDHL) Change in Inventory (2017 - 2022)
RedHill Biopharma has reported Change in Inventory over the past 6 years, most recently at $1.6 million for Q4 2022.
- Quarterly Change in Inventory rose 192.87% to $1.6 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2022, up 145.88% year-over-year, with the annual reading at -$375000.0 for FY2025, 150.81% down from the prior year.
- Change in Inventory was $1.6 million for Q4 2022 at RedHill Biopharma, up from -$865000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $2.6 million in Q2 2022 and troughed at -$4.4 million in Q3 2021.
- The 5-year median for Change in Inventory is -$325000.0 (2018), against an average of -$517850.0.
- Year-over-year, Change in Inventory crashed 1905.06% in 2020 and then surged 403.55% in 2022.
- A 5-year view of Change in Inventory shows it stood at -$300000.0 in 2018, then surged by 126.33% to $79000.0 in 2019, then crashed by 1905.06% to -$1.4 million in 2020, then fell by 18.93% to -$1.7 million in 2021, then soared by 192.87% to $1.6 million in 2022.
- Per Business Quant, the three most recent readings for RDHL's Change in Inventory are $1.6 million (Q4 2022), -$865000.0 (Q3 2022), and $2.6 million (Q2 2022).